Glenmark gets US FDA marketing approval for Meloxicam generic
Thursday, July 20, 2006 15:30 IST Our Bureau, Mumbai
Mumbai based Glenmark Pharmaceuticals Limited has received US FDA approval to market Meloxicam oral tablets 7.5 mg and 15 mg, a generic version of Boehringer Ingelheim's brand Mobic.